AWM
AXSM icon

Atticus Wealth Management’s Axsome Therapeutics AXSM Stock Holding History

Atticus Wealth Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15
Closed -$1.21K – 528
2024
Q2 		$1.21K Hold
15
– – ﹤0.01% 483
2024
Q1 		$1.2K Hold
15
– – ﹤0.01% 503
2023
Q4 		$1.19K Hold
15
– – ﹤0.01% 507
2023
Q3 		$1.05K Sell
15
-5
-25% -$374 ﹤0.01% 535
2023
Q2 		$1.44K Hold
20
– – ﹤0.01% 516
2023
Q1 		$1.23K Sell
20
-1,000
-98% -$65.7K ﹤0.01% 492
2022
Q4 		$78.7K Sell
1,020
-80
-7% -$4.78K 0.03% 202
2022
Q3 		$42K Hold
1,100
– – 0.02% 252
2022
Q2 		$42K Sell
1,100
-100
-8% -$3.16K 0.02% 274
2022
Q1 		$50K Buy
1,200
+300
+33% +$9.3K 0.02% 249
2021
Q4 		$34K Hold
900
– – 0.01% 268
2021
Q3 		$30K Buy
+900
New +$35.1K 0.01% 283

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return